Top Premarket Decliners

MT Newswires Live08-10 19:28

Sionna Therapeutics (SION) shares were down more than 92% premarket Monday after the company said that a phase 2a proof-of-concept trial for its cystic fibrosis drug, SION-719, failed to meet its primary efficacy endpoint.

Tenax Therapeutics (TENX) stock was more than 82% lower after the company said a phase 3 clinical trial of its primary drug candidate, TNX-103, failed to meet its primary endpoint.

MasterBeef Group (MB) shares were down more than 30% following an over 137% rise at Friday's close.

AirSculpt Technologies (AIRS) stock was more than 20% lower following the company's Q2 financial results.

Big Tree Cloud (DSY) shares were down 18%, swinging from the previous session's nearly 36% increase.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment